Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Suzhou Hoho Health Co. Ltd. operates a company patent portfolio within the Biotechnology & Pharmaceuticals technology area. The current prosecution landscape features 1 pending office action. This action is handled by 1 distinct examiner, TURPIN, ZACHARY MARK, who is the sole examiner identified in the portfolio. The activity is localized in a distinct art unit, which points to a concentrated technical scope for the company's health applications. TURPIN, ZACHARY MARK is the busiest examiner, overseeing the busiest examiner pending action.
For a practitioner, the presence of 1 pending office action suggests a focused stage of portfolio development. Since a distinct examiner and a distinct art unit are involved, the prosecution strategy can be optimized for the specific examination environment of TURPIN, ZACHARY MARK. The fact that the busiest examiner pending action is handled by this individual means that all current USPTO interactions are centralized. This streamlined profile in the Biotechnology & Pharmaceuticals sector facilitates direct management of the company's patent assets and health claims.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TURPIN, ZACHARY MARK | 1 | 4.0% | -5.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17618239 | METHODS AND COMPOSITIONS FOR LUNG CANCER DETECTION | TURPIN, ZACHARY MARK | 53d overdue |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17618239 | METHODS AND COMPOSITIONS FOR LUNG CANCER DETECTION | TURPIN, ZACHARY MARK | 1682 | §101§103§112Other | Final Rejection | 53d overdue | Pending | Dec 10, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial